Predictors of response to targeted therapy in renal cell carcinoma
Predictors of response to targeted therapy in renal cell carcinoma
About this item
Full title
Author / Creator
Publisher
United States: College of American Pathologists
Journal title
Language
English
Formats
Publication information
Publisher
United States: College of American Pathologists
Subjects
More information
Scope and Contents
Contents
The prognosis for patients with metastatic renal cell carcinoma is poor, with an average 5-year survival of approximately 10%. Use of traditional cytokine therapy, specifically high-dose interleukin 2, is limited by significant toxicity. Better understanding of the molecular pathogenesis of renal cell carcinoma has led to the development of targete...
Alternative Titles
Full title
Predictors of response to targeted therapy in renal cell carcinoma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1356454577
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1356454577
Other Identifiers
ISSN
0003-9985,1543-2165
E-ISSN
1543-2165
DOI
10.5858/arpa.2010-0308-RA
